Citius Pharmaceuticals   Report issue

For profit Phase 2 Phase 3
Founded: Cranford NJ United States (2007)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2015
NCT02689856
First Marketed Drug
2011
phentermine (wyamine)
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Citius Pharmaceuticals | Citius Pharmaceuticals, Inc. | CITIUS PHARMS

Active Ingredients

Marketed Drugs (1)

phentermine (wyamine) (2011)

Drugs in Phase 3 Trials (3)

Key: Citius Pharmaceuticals (0) Acquired (3)

ethanol (1 trial)

heparin (liquaemin) (1 trial)

minocycline (minocin) (1 trial)

Drugs in Phase 2 Trials (3)

halobetasol (ultravate) (1 trial)

lidocaine (xylocaine) (2 trials)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhoids (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 6